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Xenotropic MLV-related retrovirus (XMRV) was first
reported about 5 years ago in a few cases of prostate
cancer, but did not attract much attention until its
reported association with a large fraction of chronic fati-
gue syndrome cases about 2 years ago. The publication
of the XMRV-CFS connection created a ripple of excite-
ment and interest in the scientific, medical, and patient
communities reminiscent of the reports of the associa-
tion of another retrovirus—HIV-with AIDS some 25
years previously. Although I was not directly involved in
either discovery at the time, I was a very interested
observer who had been working with various retro-
viruses and who subsequently became involved in both
HIV and XMRV research, and I will offer some observa-
tions on the parallels and differences between the two.
It is noteworthy, that, within 2 years of the first report,
in 1983, of the virus we now call HIV, the key findings
were widely replicated by virologists using a variety of
different assays. By contrast, most of the results of the
XMRV paper - isolation of infectious virus from
patients, frequent detection of virus in plasma and
PBMCs by PCR, detection of antiviral antibodies -
remain to be replicated outside of the laboratories that
authored the original report despite considerable effort
worldwide. HIV is now known as the cause of a global
pandemic responsible for large numbers of deaths
annually and considerable hardship and economic loss.
By contrast, XMRV is considered by most virologists to
be the consequence of a collection of artifacts originat-
ing from endogenous murine leukemia viruses prevalent
in laboratory and wild mice.
In this talk, I will discuss our recent work that uncov-
ered how these associations arose and how even experi-
enced retrovirologists were misled by the initial reports.
There are several related, but distinct, issues that need
to be considered. First, various mouse (Mus musculus)
subspecies carry over a hundred different endogenous
proviruses closely (>90%) related to XMRV in their
DNA. Second, mice are extremely widespread, as is their
DNA, which can be found sporadically on laboratory
surfaces, as well as contaminants of common reagents
and materials. Sensitive PCR assays can detect “XMRV”
related sequences in DNA from tiny fractions of one
cell. To detect such contamination, we developed a
more sensitive assay based on mouse IAP sequences
present in thousands of copies per cell. Third, although
only a few of the endogenous MLV proviruses encode
infectious virus, it has been known since the 1970s that
some of them can give rise to virus that can infect
human tumor lines when passaged through nude mice.
Indeed, A virus identical to XMRV is produced by the
22RV1 prostate cancer line that was derived in just this
way In initial reports, however, XMRV did not appear
to be sufficiently similar to known proviruses to have
been derived this way. However, we have recently
shown that this is exactly how it did arise, but not from
infection of the precursor CWR22 xenograft with a sin-
gle virus, but rather with a recombinant between the
progeny of two previously undescribed proviruses found
in the nude mice used for passage. Since the predicted
recombinant is ancestral to all XMRV isolates, and can-
not have arisen more than once, it must have found its
way into many laboratories as the 22Rv1 cell line was
distributed worldwide and, by means that remain to be
worked out, into clinical samples from CFS patients.
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